Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could the way you push during labor reduce pain and fatigue?

NCT ID NCT07316348

Symptom relief Sponsor: Istanbul University - Cerrahpasa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two different pushing methods during the second stage of labor: vocalization (making low sounds while pushing) and spontaneous pushing (following your body's natural urges). The goal is to see which technique leads to less pain, less fatigue, less tearing, and a better birth experience for first-time mothers. About 112 women will participate, and the results may help guide future birth recommendations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 112 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for the Study: * Being 18 years of age or older * Being nulliparous * Being at term (between 38 and 42 weeks of gestation) * Expecting a vaginal delivery * Having a singleton pregnancy * Presenting in vertex position * Estimated fetal weight between 2500-4000 g * Having had a complication-free pregnancy in terms of both mother and fetus * Not having any perinatal risks * Not having received any analgesia or anesthesia to relieve pain and fatigue during labor * Being able to read, understand, and write Turkish * Voluntarily agreeing to participate in the study Exclusion Criteria: * Being multiparous * Having a multiple pregnancy * Having dysphonia and hearing loss * Being a high-risk pregnant woman * Having any systemic, chronic, or neurological disease * Pregnant women with fetal risk (presentation anomaly, cephalopelvic disproportion, macrosomia, SGA, fetal death, fetus without gross pathology according to ultrasound) Endpoints for Cases Included in the Study: * Loss of the baby during labor or delivery * Delivery by cesarean section * Pharmacological intervention to relieve pain and fatigue during labor

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LABOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain Personal Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LABOR Maternal fatigue Maternal pushing techniques Perineal trauma Second stage of labor

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul University Cerrahpaşa

    Istanbul, Ataşehir, 34758, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.